No Data
No Data
Wound Biologics Market Global Analysis and Forecast to 2030, Featuring Profiles of AlloSource, LifeNet Health, Smith & Nephew, Sanara MedTech, Mtf Biologics, Becton, Dickinson, MiMedx and TissueTech
Sanara MedTech CEO Steps Down, Agrees to Severance Deal
Sanara MedTech Files to Sell 255,049 Shares of Common Stock for Holders
Express News | Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $44 Price Target
Sanara MedTech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 40.04% Cantor Fitzgerald → $44 Reiterates Overweight → Overweight 03/27/2024 40.04% Cantor Fitz
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Sanara MedTech (SMTI)
No Data